Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Accelerated partial breast irradiation valid alternative to whole breast irradiation in early breast cancer

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 27.10.15
Views: 1482

Prof Vratislav Strnad - University Hospital Erlangen, Erlangen, Germany

Dr Strnad talks to ecancertv at ASTRO 2015 about the results of a phase III trial that compared accelerated partial breast irradiation (APBI) using sole interstitial multicatheter brachytherapy versus whole breast irradiation for early breast cancer.

The primary endpoint was the 5-year local control rate and this showed that APBI was as good as whole breast irradiation. This is the first trial to prove non-inferiority of APBI in comparison to whole breast irradiation, Dr Strnad says in the interview. These potentially practice-changing data mean that it is a valid alterative treatment option to whole breast irradiation.

The results are now published in The Lancet.

Read the news story for more.

Related videos

follow us

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation